• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of Reported Serious Adverse Events from the Adverse Reporting System (AERS) that were reviewed within 2 business days by a medical officer during the month (1)

Dictionary: With the enactment of the Food and Drug Administration Amendments Act of 2007, OBE was given expanded authority to develop the capacity, methods, and tools to ensure the safety of biological products over the life cycle (from development to use). A significant part of OBE oversight is directed to ensuring the safety of marketed biological products. OBE medical officers review one hundred percent of reported SAE in one or two business days. The medical reviews of reported Serious Adverse Events (SAE) are filed with the Vaccine Adverse Event Reporting System (VAERS) and with the Adverse Event Reporting System (AERS). The VAERS is a national surveillance program designed to detect possible adverse events associated with vaccines. The AERS is a computerized information database that FDA uses to monitor new adverse events and medication errors. This program measure documents the monthly workload of OBE’s review of VAERS and AERS reports. Number of Serious Adverse Events received each month includes SAEs from VAERS and AERS

Information is current as of September 30, 2012

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercentage
Oct 2011N/A100
Nov 2011N/A100
Dec 2011N/A100
Jan 2012N/A100
Feb 2012N/A100
Mar 2012N/A100
Apr 2012N/A100
May 2012N/A100
Jun 2012N/A100
Jul 2012N/A100
Aug 2012N/A100
Sep 2012N/A100

FY 2012 Overall: 100%

Footnotes

  • (1) Tracking against these measures did not start until January 2011.

Number of Serious Adverse Events received each month from the Adverse Event Reporting System (AERS) (1)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A316
Nov 2011N/A339
Dec 2011N/A360
Jan 2012N/A262
Feb 2012N/A336
Mar 2012N/A318
Apr 2012N/A397
May 2012N/A272
Jun 2012N/A276
Jul 2012N/A436
Aug 2012N/A268
Sep 2012N/A287

FY 2012 Total: 3,867

Footnotes

  • (1) Tracking against these measures did not start until January 2011.

Number of Reported Serious Adverse Events from the Adverse Event Reporting System (AERS) that were reviewed within 2 business days by a medical officer during the month (1)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A316
Nov 2011N/A339
Dec 2011N/A360
Jan 2012N/A262
Feb 2012N/A336
Mar 2012N/A318
Apr 2012N/A397
May 2012N/A272
Jun 2012N/A276
Jul 2012N/A436
Aug 2012N/A268
Sep 2012N/A287

FY 2012 Total: 3,867

Footnotes

  • (1) Tracking against these measures did not start until January 2010

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.